The findings in the intention-to-treat and per-protocol analysis ... for unresolving ARDS. Patients randomized to methylprednisolone treatment had a significant reduction in duration of mechanical ...

The company’s lead product candidate, ARDS-003, is a new molecular entity ... with SARS and MERS has revealed that corticosteroid treatment could exacerbate lung injury in infected patients.

These models can link real-time sensor data to personalized treatment protocols, potentially improving the efficiency and effectiveness of care for ARDS patients[4]. This shift towards more ...

Healios KK (JP:4593) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly ...

The approval is for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome or ARDS who are receiving systemic corticosteroids as part of standard care and ...